Sales up over 60% and product penetration good with 20 of of the world's top 20 pharmaceutical companies now customers
Personal Chemistry has announced its results for the half year ended 30 June 2002.
Sales of Personal Chemistry's products rose by 63% over the comparable period in 2001.
The company has consolidated its position as a supplier of instruments, knowledge products and consumables based on microwave technology for medicinal chemistry with 20 of the world's top 20 pharmaceutical companies now using Coherent Synthesis.
Future prospects for growth in sales were boosted by a recent deal with Amersham Biosciences for the distribution of Personal Chemistry's products in Japan.
Summarising results for the first half year 2002, Personal Chemistry's CFO, Fredrik Ohrn concluded: "We continue to see very strong acceptance for our products and orders have more than doubled over the last year.
With the launch of our new instrument and the new knowledge products including a proprietary database we are in a very strong position to establish Coherent Synthesis as an integral part of pharmaceutical research".
